Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd
1 clinical trials · Sponsor
◉ Watch Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd
| Record | Firm | Date |
|---|---|---|
| Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment (NCT04620109) | Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd | 2020-08-26 |
Track Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.